CH403768A - Process for the preparation of new iminodibenzyl derivatives - Google Patents
Process for the preparation of new iminodibenzyl derivativesInfo
- Publication number
- CH403768A CH403768A CH152962A CH152962A CH403768A CH 403768 A CH403768 A CH 403768A CH 152962 A CH152962 A CH 152962A CH 152962 A CH152962 A CH 152962A CH 403768 A CH403768 A CH 403768A
- Authority
- CH
- Switzerland
- Prior art keywords
- methyl
- formula
- chloride
- acid
- radical
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 5
- ZSMRRZONCYIFNB-UHFFFAOYSA-N 6,11-dihydro-5h-benzo[b][1]benzazepine Chemical class C1CC2=CC=CC=C2NC2=CC=CC=C12 ZSMRRZONCYIFNB-UHFFFAOYSA-N 0.000 title description 3
- 238000002360 preparation method Methods 0.000 title description 3
- -1 alkylene radical Chemical class 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 4
- 150000001414 amino alcohols Chemical class 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical group C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229960003750 ethyl chloride Drugs 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical group O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WNRWEBKEQARBKV-UHFFFAOYSA-N 1-(2-chloroethyl)piperidine Chemical compound ClCCN1CCCCC1 WNRWEBKEQARBKV-UHFFFAOYSA-N 0.000 description 1
- HDDNBUNZJIQDBQ-UHFFFAOYSA-N 1-(3-chloropropyl)piperidine Chemical compound ClCCCN1CCCCC1 HDDNBUNZJIQDBQ-UHFFFAOYSA-N 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- FFOIFAAVWJZLFE-UHFFFAOYSA-N 3-(chloromethyl)-1-methylpiperidine Chemical compound CN1CCCC(CCl)C1 FFOIFAAVWJZLFE-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- SOMIBONUMGNAEP-UHFFFAOYSA-N 3-chloro-n,n,2-trimethylpropan-1-amine;hydron;chloride Chemical compound Cl.ClCC(C)CN(C)C SOMIBONUMGNAEP-UHFFFAOYSA-N 0.000 description 1
- ZAPMTSHEXFEPSD-UHFFFAOYSA-N 4-(2-chloroethyl)morpholine Chemical compound ClCCN1CCOCC1 ZAPMTSHEXFEPSD-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 description 1
- 125000005277 alkyl imino group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung von neuen Iminodibenzylderivaten Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von neuen N-heterocyclischen Ver bindungen mit wertvollen pharmakologischen Eigen schaften.
In einem Benzolring durch einen Alkylsulfonyl- rest substituierte Iminodibenzylderivate sind bisher nicht bekannt geworden.
Es wurde nun gefunden, dass solche Verbindungen der Formel I,
EMI0001.0015
in der R einen Methyl- oder einen Äthylrest, Z einen geradkettigen oder verzweigtem Al- kylenrest mit 2-4 Kohlenstoffatomen, und Am eine niedere Dialkylaminogruppe bedeuten,
wobei auch ein Alkylrest von Am direkt mit dem Alkylenrest Z oder beide Alkylreste einer Dialkylaminogruppe Am unter sich direkt oder über ein Sauerstoffatom, eine niedere Alkylimino-, Hy- droxyalkylimino- oder Alkanoyloxyalkyliminogruppe verbunden sein können, sowie deren Salze mit an organischen oder organischen Säuren, wertvolle phar- makologische Eigenschaften, insbesondere antialler gische,
antiemetische und sedative Wirksamkeit be sitzen, sowie auch die Wirkung anderer Arzneistoffe, insbesondere von Narkotica, potenzieren.
In den Verbindungen der Formel I ist Z beispiels weise ein Äthylen-, Propylen-, Trimethylen-, 1-Me- thyl-trimethylen-, 2-Methyl-trimethylen- oder ein Te- tramethylenrest und Am z.
B. ein Dimethylamino-, Methyl-äthylamino-, Diäthylamino-, Methyl-n-propyl- amino-, Methyl-isopropylamino-, Di-n-butylamino-, Di-isobutylamino-, 1-Pyrrolidinyl-, Piperidino-, Hexa- methylenimino-, Morpholino-, 4-Methyl-l-piperazi- nyl-, 4-Iso@propyl-1 piperazinyl-, 4-(ss-Hydroxyäthyl)
- 1-piperazinyl-, 4-(ss Acetoxyäthyl)-1-piperazmyl- oder 4-ss-Hydroxy-propyl-l-piperazinyl-rest. Ferner kann Am zusammen mit Z z. B. den ss-(1-Methyl-2-pyrro- lidinyl)-äthyl-, 1-Methyl-3-pyrrolidinylmethyl-, ss-(1 Methyl-piperidyl)-äthyl-, 1-Methyl-3-piperidylmethyl- oder 1-Methyl-4-piperidylrest bedeuten.
Erfindungsgemäss werden die neuen Verbindun gen der Formel I erhalten, indem man eine Verbin dung der Formel II,
EMI0001.0079
in Gegenwart eines basischen Kondensationsmittels mit einem reaktionsfähigen Ester eines Aminoalko- hols der Formel III, HO-Z-Am (III) umsetzt.
Als Kondensationsmittel eignen sich insbesondere Natriumamid, Lithiumamid, Kaliumamid, Natrium oder Kalium, Butyllithium, Phenyllithium oder Li- thiumhydrid. Die Umsetzung kann in An- oder Ab wesenheit eines inerten organischen Lösungsmittels, wovon als Beispiele Benzol, Toluol und Xylole ge nannt seien, durchgeführt werden.
Ausgangsstoffe der Formel Il sind das 3-Methyl- sulfonyl- und das 3-Äthylsulfonyl-iminodibenzyl, wel- ehe z. B. ausgehend von 3-Anüno-5-acetyl-imino- dibenzyl erhalten werden können, indem man dieses in das entsprechende Diazoniumsulfat überführt und letzteres in schwefelsaurer Lösung nach Zusatz von Kupferpulver mit Schwefeldioxyd behandelt,
die er- haltene 5-Acetyl-iminodibenzyl-3-sulfinsäure in ihr Natriumsalz überführt, diese mit einem geeigneten Methyl- oder Äthylhalogenid umsetzt und schliess- lich den Acetylrest durch Hydrolyse, z. B. mittels äthanolischer oder methanolischer Kaliumhydroxyd- lösung, abspaltet.
Als reaktionsfähige Ester von Aminoalkoholen der Formel III können insbesondere die Halogenide in Frage kommen, im einzelnen seien genannt:
f:-Dimethylamino-äthylehlorid, '>-Diäthylamino-äthylchlorid, P-Methyläthylamino-äthylchlorid, ss-Dimethylamino-propylchlorid, ss-Dimethylamino-isopropylchlorid, y-Dimethylamino-propylchlorid, y Dimethylamino-butylehlorid, a-Dimethylamino-butylchlorid, y-Dimethylamino-ss-methyl-propylchlorid, a-Methyl-y-dimethylamino-n-amylchlorid, ss-(Di-n-propylamino)-äthylchlorid, ss-(Methyl-isopropyl-amino)-äthylchlorid,
ss-(Di-n-butylamino)-äthylchlorid, P-(Di-isobutylamino)-äthylchlorid, ss-(1-Pyrrolidinyl)-äthylchlorid, ss-Piperidino-äthylclilorid, -(1-Pyrrolidinyl)-propylchlorid, y-Piperidino-propylchlorid, ss-Morpholino-äthylchlorid, y-Morpholino-propylchlorid, ss-(4-Methyl-l-piperazinyl)-äthylchlorid, y-(4-Methyl-l-piperazinyl)-propylchlorid, ss-[4-(ss-Acetaxy-äthyl)-1-piperazinyll-äthyl- chlorid,
y-[4-(ss-Acetoxy-äthyl)-1 piperazinyl]-propyl- chlorid, ss-(1-Methyl-2-pyrrolidinyl)-äthylchlorid, ss-(1-Methyl-2-piperidyl)-äthylchlorid und (1-Methyl-3-piperidyl)-methylchlorid, sowie die entsprechenden. Bromide und Jodide.
Mit anorganischen oder organischen Säuren, wie Salzsäure, Bromwasserstoffsäure, Schwefelsäure, Phosphorsäure, Methansulfonsäure, Äthandisulfon- säure, ss-Hydroxyäthansulfonsäure, Essigsäure, Bern steinsäure, Fumarsäure, Maleinsäure, Äpfelsäure, Weinsäure, Citronensäure, Benzoesäure,
Salicylsäure und Mandelsäure bilden die tertiären Basen Salze, welche zum Teil wasserlöslich sind.
Im nachfolgenden Beispiel bedeuten Teile Ge wichtsteile, die sich zu Volumteilen wie g zu cm' verhalten. Die Temperaturen sind in Celsiusgraden angegeben.
<I>Beispiel</I> a) 25,2 Teile 3-Amino-5-acetyl-iminodibenzyl werden in 150 Volumteilen Wasser und 30 Volum- teilen konz. Schwefelsäure gelöst und bei O unter Rühren mit 7 Teilen Natriumnitrit in 20 Volumteilen Wasser diazotiert. Hierauf wird die Lösung mit Schwefeldioxyd unter Kühlung in einem EisrKoch- salzbad gesättigt.
Unter weiterem schwachem Durch leiten von Schwefeldioxyd wird Kupferpulver in klei nen Portionen zugegeben. Nach Beendigung der Stickstoffentwicklung wird die Sulfinsäure mit Chlo roform extrahiert und der getrocknete Extrakt ein geengt. Aus Aceton-Äther umkristallisiert, schmilzt die 5-Acetyl-iminodibenzyl-3-sulfinsäure unter Zer setzung bei 154 .
b) 30,1 Teile 5-Acetyl-iminodibenzyl-3-sulfinsäure werden zur Lösung von 2,3 Teilen Natrium in 250 Volumteilen abs. Äthanol gegeben und mit 16 Teilen Methyljodid versetzt. Nach verstündigem Erhitzen un ter Rückfluss wird das Äthanol abdestilliert. Der Rückstand wird in Chloroform aufgenommen und mit wenig Wasser gewaschen.
Die getrocknete Chloro- formlösung wird eingeengt und mit Petroläther ver- setzt. Die abgeschiedenen Kristalle schmelzen bei 153 bis 154 und sind reines 3-Methylsulfonyl-5-acetyl- iminodibenzyl.
c) 31,5 Teile 3-Methylsulfonyl-5-acetyl-iminodi- benzyl werden in 500 Volumteilen Äthylenglykol, enthaltend 25 Teile Kaliumhydroxyd, durch 16-stün- diges Kochen unter Rückfluss hydrolysiert. Das Reak tionsgemisch wird auf Wasser gegossen und die Kri stalle werden abgenutscht. Reines 3-Methylsulfonyl- inlinodibenzyl schmilzt, aus Äther umkristallisiert, bei 175-176 .
d) 27,3Teile3-Methylsulfonyl-iminodibenzyl wer den bei 80 in 800 Volumteilen abs. Xylol gelöst und mit 20,9 Teilen 3-Dimethylamino-2-methyl-l-propyl- chlorid-hydrochlorid versetzt.
Hierauf werden 8,6 Teile in Toluol pulverisiertes Natriumamid zugetropft, und das Reaktionsgemisch wird während 17 Stunden bei 135 gerührt. Nach dem Abkühlen wird die Base mit 2-n. Salzsäure extrahiert, der Extrakt alkalisch gestellt und in Äther aufgenommen. Nach dem Ein dampfen der getrockneten Ätherlösung verbleibt die Base als ein Öl.
Aus dieser Base wird in üblicher Weise das Hydrochlorid hergestellt und dieses aus viel Methyläthyketon umkristallisiert. Das. 3-Methyl sulfonyl-5-[(3-dimethylamino-2-methyl)-propyl]-imi- no-dibenzyl-hydrochlorid schmilzt bei<B>229-231'.</B>
Process for the preparation of new iminodibenzyl derivatives The present invention relates to a process for the preparation of new N-heterocyclic compounds with valuable pharmacological properties.
Iminodibenzyl derivatives substituted in a benzene ring by an alkylsulfonyl radical have not yet become known.
It has now been found that such compounds of the formula I,
EMI0001.0015
in which R is a methyl or an ethyl radical, Z is a straight-chain or branched alkylene radical with 2-4 carbon atoms, and Am is a lower dialkylamino group,
where an alkyl radical of Am can also be linked directly to the alkylene radical Z or both alkyl radicals of a dialkylamino group Am directly or via an oxygen atom, a lower alkylimino, hydroxyalkylimino or alkanoyloxyalkylimino group, and their salts with organic or organic acids, valuable pharmacological properties, especially anti-allergic,
have antiemetic and sedative efficacy, as well as potentiate the effect of other drugs, especially narcotics.
In the compounds of the formula I, Z is, for example, an ethylene, propylene, trimethylene, 1-methyl-trimethylene, 2-methyl-trimethylene or tetramethylene radical, and Am is z.
B. a dimethylamino, methyl ethylamino, diethylamino, methyl-n-propylamino, methyl-isopropylamino, di-n-butylamino, di-isobutylamino, 1-pyrrolidinyl, piperidino, hexa- methylenimino, morpholino, 4-methyl-l-piperazinyl, 4-iso @ propyl-1 piperazinyl, 4- (ss-hydroxyethyl)
- 1-piperazinyl, 4- (ss acetoxyethyl) -1-piperazmyl or 4-ss-hydroxypropyl-1-piperazinyl radical. Furthermore, Am together with Z z. B. the ss- (1-methyl-2-pyrrolidinyl) ethyl, 1-methyl-3-pyrrolidinylmethyl, ss- (1 methyl-piperidyl) -ethyl, 1-methyl-3-piperidylmethyl or 1-methyl-4-piperidyl radical.
According to the invention, the new compounds of the formula I are obtained by adding a compound of the formula II,
EMI0001.0079
in the presence of a basic condensing agent with a reactive ester of an amino alcohol of the formula III, HO-Z-Am (III).
Sodium amide, lithium amide, potassium amide, sodium or potassium, butyllithium, phenyllithium or lithium hydride are particularly suitable as condensing agents. The reaction can be carried out in the presence or absence of an inert organic solvent, examples of which are benzene, toluene and xylenes.
Starting materials of the formula II are 3-methylsulfonyl- and 3-ethylsulfonyl-iminodibenzyl, wel- before z. B. starting from 3-Anüno-5-acetyl-imino-dibenzyl can be obtained by converting this into the corresponding diazonium sulfate and treating the latter in sulfuric acid solution after adding copper powder with sulfur dioxide,
the 5-acetyl-iminodibenzyl-3-sulfinic acid obtained is converted into its sodium salt, this is reacted with a suitable methyl or ethyl halide and finally the acetyl radical is removed by hydrolysis, e.g. B. by means of ethanolic or methanolic potassium hydroxide solution, split off.
Particularly suitable reactive esters of amino alcohols of the formula III are the halides;
f: -Dimethylamino-ethyl chloride, '> -diethylamino-ethyl chloride, P-methylethylamino-ethyl chloride, s-dimethylamino-propyl chloride, s-dimethylamino-isopropyl chloride, y-dimethylamino-propyl chloride, y-dimethylamino-butyl chloride, y-dimethylamino-butyl chloride -Dimethylamino-ss-methyl-propyl chloride, a-methyl-y-dimethylamino-n-amyl chloride, ss- (di-n-propylamino) -ethyl chloride, ss- (methyl-isopropyl-amino) -ethyl chloride,
ss- (di-n-butylamino) ethyl chloride, P- (di-isobutylamino) ethyl chloride, ss- (1-pyrrolidinyl) ethyl chloride, ss-piperidinoethyl chloride, - (1-pyrrolidinyl) propyl chloride, γ-piperidino propyl chloride, ss-morpholino-ethyl chloride, y-morpholino-propyl chloride, ss- (4-methyl-l-piperazinyl) ethyl chloride, y- (4-methyl-l-piperazinyl) propyl chloride, ss- [4- (ss -Acetaxy-ethyl) -1-piperazinyll-ethyl chloride,
y- [4- (ss-acetoxy-ethyl) -1 piperazinyl] -propyl chloride, ss- (1-methyl-2-pyrrolidinyl) -ethyl chloride, ss- (1-methyl-2-piperidyl) -ethyl chloride and ( 1-methyl-3-piperidyl) methyl chloride, and the corresponding. Bromides and iodides.
With inorganic or organic acids, such as hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, methanesulphonic acid, ethane disulphonic acid, β-hydroxyethanesulphonic acid, acetic acid, succinic acid, fumaric acid, maleic acid, malic acid, tartaric acid, citric acid, benzoic acid,
Salicylic acid and mandelic acid form the tertiary base salts, some of which are water-soluble.
In the following example, parts mean parts by weight which are related to parts by volume as g to cm '. The temperatures are given in degrees Celsius.
<I> Example </I> a) 25.2 parts of 3-amino-5-acetyl-iminodibenzyl are concentrated in 150 parts by volume of water and 30 parts by volume. Dissolved sulfuric acid and diazotized at 0 with stirring with 7 parts of sodium nitrite in 20 parts by volume of water. The solution is then saturated with sulfur dioxide while cooling in an ice / salt bath.
Copper powder is added in small portions with a further weak passage of sulfur dioxide. After the evolution of nitrogen has ended, the sulfinic acid is extracted with chloroform and the dried extract is concentrated. Recrystallized from acetone ether, 5-acetyl-iminodibenzyl-3-sulfinic acid melts with decomposition at 154.
b) 30.1 parts of 5-acetyl-iminodibenzyl-3-sulfinic acid are abs to dissolve 2.3 parts of sodium in 250 parts by volume. Given ethanol and mixed with 16 parts of methyl iodide. After one hour of refluxing, the ethanol is distilled off. The residue is taken up in chloroform and washed with a little water.
The dried chloroform solution is concentrated and petroleum ether is added. The deposited crystals melt at 153 to 154 and are pure 3-methylsulfonyl-5-acetyl-iminodibenzyl.
c) 31.5 parts of 3-methylsulfonyl-5-acetyl-iminodibenzyl are hydrolyzed in 500 parts by volume of ethylene glycol containing 25 parts of potassium hydroxide by refluxing for 16 hours. The reaction mixture is poured into water and the crystals are suction filtered. Pure 3-methylsulfonylinlinodibenzyl melts, recrystallized from ether, at 175-176.
d) 27.3 parts of 3-methylsulfonyl-iminodibenzyl who abs at 80 in 800 parts by volume. Dissolved xylene and treated with 20.9 parts of 3-dimethylamino-2-methyl-1-propyl chloride hydrochloride.
Then 8.6 parts of sodium amide pulverized in toluene are added dropwise and the reaction mixture is stirred at 135 for 17 hours. After cooling, the base with 2-n. Hydrochloric acid extracted, the extract made alkaline and taken up in ether. After evaporating the dried ether solution, the base remains as an oil.
The hydrochloride is prepared from this base in the usual way and this is recrystallized from a large amount of methyl ethyl ketone. The. 3-Methyl sulfonyl-5 - [(3-dimethylamino-2-methyl) propyl] -imino-dibenzyl hydrochloride melts at <B> 229-231 '. </B>
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH152962A CH403768A (en) | 1962-02-08 | 1962-02-08 | Process for the preparation of new iminodibenzyl derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH152962A CH403768A (en) | 1962-02-08 | 1962-02-08 | Process for the preparation of new iminodibenzyl derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH403768A true CH403768A (en) | 1965-12-15 |
Family
ID=4212564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH152962A CH403768A (en) | 1962-02-08 | 1962-02-08 | Process for the preparation of new iminodibenzyl derivatives |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH403768A (en) |
-
1962
- 1962-02-08 CH CH152962A patent/CH403768A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH349986A (en) | Process for the preparation of new basic substituted heterocycles | |
| DE2824554A1 (en) | 1-PHENYL-3,3-DICHLORO-2-AZETIDINONE | |
| CH403768A (en) | Process for the preparation of new iminodibenzyl derivatives | |
| AT233014B (en) | Process for the preparation of new iminodibenzyl derivatives | |
| CH638525A5 (en) | 3- (TETRAZOL-5-YL) -1-AZAXANTHONE AND METHOD FOR THE PRODUCTION THEREOF. | |
| DE1620188A1 (en) | Process for the preparation of dibenzocycloheptatriene derivatives | |
| DE1300954B (en) | Process for the production of dibenzothiepin and oxepines | |
| DE1161279B (en) | Process for the preparation of azepinone derivatives and their salts | |
| AT217045B (en) | Process for the preparation of new monoalkylated or monohalogenated N-derivatives of 10,11-dihydro-5H-dibenzo [b, f] azepines and 5H-dibenzo [b, f] azepines | |
| AT233016B (en) | Process for the preparation of new iminodibenzyl derivatives | |
| AT222128B (en) | Process for the preparation of new N-heterocyclic compounds | |
| DE1443983C3 (en) | Process for the preparation of aminoalkylidene compounds of dibenzo square brackets on a, square brackets on -cycloheptene or thioxanthene from the associated 5- and 9-keto compounds | |
| AT240866B (en) | Process for the production of basic substituted dibenzo derivatives | |
| CH413825A (en) | Process for the production of new amines | |
| AT222130B (en) | Process for the preparation of new N-heterocyclic compounds | |
| AT247339B (en) | Process for the production of new quinazolone compounds | |
| AT214934B (en) | Process for the preparation of new N-derivatives of 10,11-dihydro-5-benzo [b, f] azepines and 5-dibenzo [b, f] azepines | |
| AT219606B (en) | Process for the preparation of new N-heterocyclic compounds and their salts | |
| AT233552B (en) | Process for the preparation of new dibenzocycloheptadiene derivatives and their salts | |
| AT220624B (en) | Process for the preparation of new N-heterocyclic compounds | |
| AT208869B (en) | Process for the production of new N-substituted azepines | |
| AT208871B (en) | Process for the production of new N-substituted azepines or dihydroazepines | |
| DE1470215A1 (en) | New heterocyclic compounds and processes for their preparation | |
| CH385853A (en) | Process for the preparation of new iminodibenzyl derivatives | |
| AT233581B (en) | Process for the preparation of new iminodibenzyl derivatives |